Related Experiment Videos
Epidemiology of hepatitis C virus infection in a suburban Detroit community
1Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan.
Insights
Hepatitis C virus (HCV) infection in suburban America often lacks identifiable risk factors, with sporadic transmission playing a key role, particularly in older individuals and those from outside North America.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Background:
- Chronic hepatitis C virus (HCV) infection is a significant global health concern.
- Identifying transmission routes and risk factors is crucial for effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the epidemiological characteristics and risk factors associated with hepatitis C virus (HCV) infection in a suburban American population.
- To determine the prevalence of identifiable risk factors and explore patterns of sporadic transmission.
Main Methods:
- Serum analysis for anti-HCV antibodies in 50 patients with suspected chronic non-A, non-B hepatitis.
- Detailed patient history collection, including blood transfusions, intravenous drug use, and tattoo application.
- Liver biopsy in a subset of patients to assess liver disease severity.
- Statistical analysis to identify age-related epidemiological differences.
Main Results:
- Blood transfusions (58%) and intravenous drug use (22%) were primary identified risk factors.
- A significant age-related epidemiological difference was observed (p = 0.001).
- 16% of patients had no identifiable risk factors, with 63% of these born outside North America.
- 80% of biopsied patients had chronic active hepatitis or cirrhosis; 29% of cirrhotic patients had hepatocellular carcinoma.
Conclusions:
- A notable proportion of chronic hepatitis C patients in suburban America lack identifiable risk factors.
- Sporadic HCV transmission appears significant, especially in individuals over 50 and those born outside North America.
- Hepatocellular carcinoma risk is elevated in patients with HCV-related cirrhosis.
Abstract:
A serum analysis for antibodies to the hepatitis C virus (HCV) was performed on a group of patients in a large suburban Detroit community hospital. The first 50 anti-HCV-positive patients with clinically suspected chronic non-A, non-B hepatitis were studied. Blood transfusions (58%) and intravenous drug use (22%) were the source of infection in most of these patients. A significant difference in age-related epidemiology was observed (p = 0.001). A remote history of intravenous drug use or tattoo application was elicited in 55% of individuals less than 40 yr old. "Sporadic" transmission occurred in 28% of individuals older than 50 yr. Sixteen percent (8/50) had no identifiable risk factors. Five of these eight patients (63%) were born and raised outside North America. Eighty percent of the 35 persons who underwent liver biopsy were found to have either chronic active hepatitis or cirrhosis. Twenty-nine percent (5/17) of the patients with anti-HCV-related cirrhosis presented with hepatocellular carcinoma. None of the patients with noncirrhotic liver disease had a primary liver tumor. We conclude that a significant number of patients in suburban America with chronic hepatitis C have no identifiable risk factors for HCV. Sporadic transmission of hepatitis C may play an important role in patients with chronic HCV-related liver disease, especially among patients born and raised outside North America.